INTRODUCTION

50
Renal albumin handling is increasingly important in renal physiology and clinical 51 nephrology. There is evidence that increased urinary albumin excretion (albuminuria) is a 52 major risk factor for reno-cardiovascular diseases development. Albuminuria plays a causal 53 role in the development of renal disease as reduction of albuminuria delays renal disease 54 progression (8, 27) .
55
The glomerular capillary wall functions as a size-selective, multicellular glomerular 56 filtration barrier (GFB) that restricts the passage of albumin but is permeable for smaller 57 plasma molecules. GFB is organized into three interdependent layers consisting of fenestrated between 6-7 days after seeding and were treated for 1 h with 1 µmol/L 2-meSATP, ATP-γ-S 166 or 100 µmol/L 8-Br-cGMP. Afterwards, the podocytes were washed twice with PBS, and the 167 medium on both sides of the insert was replaced with serum-free RPMI 1640 medium, SFM
168
(Gibco, Invitrogen, Carlsbad, CA, USA). After 2 h, the medium in the upper compartment 169 was replaced with 0.3 ml of fresh SFM, and that in the lower compartment was replaced with 4°C by scraping. The cell homogenates were centrifuged at 9.500 × g for 20 minutes at 4 °C.
229
To obtain non-reducing conditions, maleimide (10 mmol/L) was used in the homogenization One program (Bio-Rad). Protein content was measured using the Lowry method. 
RESULTS
254
In vitro effect of P2 receptors agonists on isolated glomeruli permeability to albumin
255
The basal value of reflection coefficient of albumin, P alb (0.10±0.06, n=19) was n=8 (P<0.05) (Fig.1A) . Resistant to hydrolysis ATP analogue, 2-methylthioadenosine 259 triphosphate (2-meSATP) increased P alb in both concentration-and time-dependent manners.
260
A significant increase in P alb was observed beginning at 0.1 nmol/L 2-meSATP -0.31±0.08, 261 n=7 and maximal effect was observed with 1 µmol/L 2-meSATP -0.57±0.04, n=12 (Fig. 1B) .
262
Half-maximal effect (EC 50 ) was obtained at ∼13 nM. 2-meSATP at 1 µmol/L significantly In vivo effect of P2 receptors agonists on isolated glomeruli permeability for albumin 271 2-meSATP and ATP-γ-S (1 µmol/L) administrated subcutaneously for 7 days using 272 osmotic pumps caused a significant increase of P alb (Fig. 3) Furthermore, there was no effect of L-NAME or ODQ on control P alb (Fig. 4B) . accompanied by a decrease in fluorescence intensity in the central area of the cell (Fig. 7) .
331
The effect of 2-meSATP or ATP-γ-S on albumin uptake in primary cultured rat podocytes. an independent risk factor for the progression of chronic renal disease and cardiovascular 380 morbidity and mortality (33, 44).
381
The results of our experiments conducted on podocytes provide evidence that these we have shown that NOS inhibitor, L-NAME and cytoplasmic guanylyl cyclase inhibitor,
398
ODQ prevent the P2Rs-mediated changes in glomerular permeability to albumin. In addition,
399
by measuring the conversion of L-arginine to L-citrulline, an indicator of NOS activity, we 400 have previously shown that a short-term activation of P2Rs expressed on glomerular cells podocytes may play important role in the regulation of the glomerular filtration barrier (28).
442
The changes of GFB permeability to albumin are mediated by P2Rs, however hydrolysed to AMP, which may subsequently be a substrate for 5'-nucleotides yielding AMP 447 to adenosine (55). We provided evidence that adenosine increases GFB permeability to 448 albumin through ARs, presumably the high-affinity receptors A1R, A2AR and A3R.
449
Moreover, the effect of AMP is mediated by adenosine. It was previously shown using The effects of natural P2Rs agonists -ATP, ADP, UTP, ADP (1 µmol/L) on P alb (A).
474
Concentration-dependent effect of 2-meSATP (10 minutes) (B) and time-dependent effect of 
481
The concentration of BSA in the incubation medium was changed from 5% to 1% and then 482 back to 5%. Next glomeruli were incubated with 1 µmol/L 2-meSATP for 10 minutes and
483
BSA concentration was changed to 1%. Glomerular volume (nl) was derived from the area of 484 glomerular image calculated using CellSens Dimention Software (Olympus, Japan). 2-meSATP/buffer
